Amphista Therapeutics’ $53 Million Series B Funding Round

In UK Osborne Clarke, advised on the matter.Osborne Clarke advised Amphista Therapeutics with a team including Justin Starling (Picture – Corporate M&A).The round was co-led by…

This content is for members only.
Join Now
Already a member? Log in here

Author: Giulia Di Palma

This content is for members only.
Join Now
Already a member? Log in here